Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Prostate Cancer 2017 NCI 5R01CA172603-05 A novel strategy to identify prostate cancer biomarkers for patient management HUANG, JIAOTI DUKE UNIVERSITY NC $329,925
Prostate Cancer 2017 NIMHD 5R01MD007783-04 A Health IT based Psychoeducational Intervention for African American Prostate Cancer RIVERS, BRIAN MOREHOUSE SCHOOL OF MEDICINE GA $263,848
Prostate Cancer 2017 NCI 5R01CA166894-05 A New Mechanism for Castration Resistant Prostate Cancer SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $1
Prostate Cancer 2017 NCI 5U01CA194393-03 Quantifying and Characterizing the shared genetic contribution to common cancers LINDSTROEM, SARA UNIVERSITY OF WASHINGTON WA $566,464
Prostate Cancer 2017 NCI 5F31CA200163-02 Determining the mechanisms of selective miRNA packaging for extracellular miRNA secretion in prostate cancer HU, TIANYI UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $35,511
Prostate Cancer 2017 NCI 1K22CA207578-01 INVESTIGATING THE ROLE OF THE TRANSCRIPTIONAL COREGULATOR SRC-2 IN CASTRATION RESISTANT PROSTATE CANCER DASGUPTA, SUBHAMOY ROSWELL PARK CANCER INSTITUTE CORP NY $206,685
Prostate Cancer 2017 NCI 5R21CA191913-02 Auger Electron Radiotherapy of Late-Stage, Castration-Resistant Prostate Cancer using a Brominated Dihydrotestosterone Analogue VEACH, DARREN SLOAN-KETTERING INST CAN RESEARCH NY $229,550
Prostate Cancer 2017 NCI 5R01CA195476-02 Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer KESHARI, KAYVAN SLOAN-KETTERING INST CAN RESEARCH NY $287,816
Prostate Cancer 2017 NCI 5R01CA192669-03 Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer LARNER, JAMES UNIVERSITY OF VIRGINIA VA $412,055
Prostate Cancer 2017 NCI 5K05CA175147-04 Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention STANFORD, JANET FRED HUTCHINSON CANCER RESEARCH CENTER WA $88,959
Prostate Cancer 2017 NCI 5R01CA193331-02 Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination thru Engagement in Mindfulness Education (REASSURE ME) VICTORSON, DAVID NORTHWESTERN UNIVERSITY AT CHICAGO IL $513,284
Prostate Cancer 2017 NCI 5R01CA181605-04 Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer NELSON, PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $351,588
Prostate Cancer 2017 NIGMS 5R01GM112846-03 Multivalent higher-order complexes regulate ubiquitination in Hedgehog signaling MITTAG, TANJA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $310,984
Prostate Cancer 2017 NCI 5R21CA195313-02 Magi2 in aggressive prostate cancer MARKER, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $195,054
Prostate Cancer 2017 NCI 5R01CA190636-02 Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery NELSON, CHRISTIAN SLOAN-KETTERING INST CAN RESEARCH NY $693,571
Prostate Cancer 2017 NCI 5R01CA201430-02 p53 Variants in Cancer Risk and Therapy MURPHY, MAUREEN WISTAR INSTITUTE PA $421,358
Prostate Cancer 2017 NCI 5K07CA166462-05 Impact of Cancer on Adherence in Diabetes LIN, JENNY ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $167,805
Prostate Cancer 2017 NCI 5R01CA193739-02 Novel targeted chemo/immunotherapy approach for localized and metastatic CaP BHAT, MOHAMMAD SALEEM UNIVERSITY OF MINNESOTA MN $354,563
Prostate Cancer 2017 NCI 5R01CA101753-13 Anticarcinogenic Effect of ITCs Against Prostate Cancer SINGH, SHIVENDRA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $346,500
Prostate Cancer 2017 NCI 5R01CA181242-03 Identification of DNA methylation markers for risk of metastasis in localized pro CHAO, CHUN KAISER FOUNDATION RESEARCH INSTITUTE CA $566,816
Prostate Cancer 2017 NCI 5R01CA200844-02 Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer TORCHILIN, VLADIMIR NORTHEASTERN UNIVERSITY MA $341,201
Prostate Cancer 2017 NCI 5R01CA200787-02 Development of small molecules for ERG ablation in prostate cancer KITTLER, RALF UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Prostate Cancer 2017 NCI 5R01CA200611-02 Developing therapeutics against resistance to the androgen-deprivation therapy YU, QIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $387,731
Prostate Cancer 2017 NCI 5R01CA193829-02 Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT SMITH, GARY ROSWELL PARK CANCER INSTITUTE CORP NY $392,306
Prostate Cancer 2017 NIBIB 5R01EB016707-04 Protein Biomarker Arrays for Personalized Treatment of Prostate Cancer RUSLING, JAMES UNIVERSITY OF CONNECTICUT STORRS CT $348,141
Prostate Cancer 2017 NCI 5R01CA172220-05 Estrogen Receptors in Human Prostate Stem-Progenitor Cells PRINS, GAIL UNIVERSITY OF ILLINOIS AT CHICAGO IL $330,527
Prostate Cancer 2017 NCI 5R01CA190289-03 Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer SHARIFI, NIMA CLEVELAND CLINIC LERNER COM-CWRU OH $362,569
Prostate Cancer 2017 NCI 5R01CA183929-03 Molecular mechanisms of prostate cancer metastasis ABATE-SHEN, CORY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Prostate Cancer 2017 NCI 5R44CA192701-03 NanoCytology to mitigate overdiagnosis of prostate cancer SUBRAMANIAN, HARIHARAN NANOCYTOMICS, LLC IL $782,124
Prostate Cancer 2017 NCI 5R01CA176401-04 RB Function in Prostate Cancer Progression KNUDSEN, KAREN THOMAS JEFFERSON UNIVERSITY PA $431,269
Prostate Cancer 2017 NCI 5R00CA175291-04 CD117 Signaling as a Mechanism of Prostate Cancer Metastasis KERR, BETHANY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $249,000
Prostate Cancer 2017 NCI 5R01CA070297-19 Androgen Signaling in prostate cancer progression and CRPC development SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $1
Prostate Cancer 2017 NCI 5R01CA196232-02 Effectors of protein kinase C-mediated tumor progression KAZANIETZ, MARCELO UNIVERSITY OF PENNSYLVANIA PA $389,662
Prostate Cancer 2017 NCI 5R01CA136924-08 Prostate Cancer Risk Enhancers FARNHAM, PEGGY UNIVERSITY OF SOUTHERN CALIFORNIA CA $556,779
Prostate Cancer 2017 NIGMS 5R01GM110019-03 Molecular mechanism of mTORC1-dependent translation and ribosome biogenesis INOKI, KEN UNIVERSITY OF MICHIGAN MI $289,468
Prostate Cancer 2017 NCI 5R21CA202552-02 Comparative Effectiveness of Genomics Assay for Active Surveillance Failure Prediction in African American Men: the impact of genetic ancestry and socioeconomic status. MURPHY, ADAM NORTHWESTERN UNIVERSITY AT CHICAGO IL $174,014
Prostate Cancer 2017 NCI 5R01CA174206-05 Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer PARMIGIANI, GIOVANNI DANA-FARBER CANCER INST MA $324,548
Prostate Cancer 2017 NCI 5K22CA174841-03 PSMA Targeted Docetaxel Loaded Magnetic Nanoparticles for Prostate Cancer Therapy YALLAPU, MURALI UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $160,992
Prostate Cancer 2017 NCI 5R01CA181189-04 Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer PODGORSKI, IZABELA WAYNE STATE UNIVERSITY MI $315,400
Prostate Cancer 2017 NCI 5P30CA008748-51 7555 Antitumor DE STANCHINA, ELISA SLOAN-KETTERING INST CAN RESEARCH NY $253,618
Prostate Cancer 2017 NCI 5P30CA008748-51 7564 Organic Sythesis OUERFELLI, OUATHEK SLOAN-KETTERING INST CAN RESEARCH NY $342,882
Prostate Cancer 2017 NCI 5P30CA008748-51 7575 Web Survey Core VICKERS, ANDREW SLOAN-KETTERING INST CAN RESEARCH NY $166,422
Prostate Cancer 2017 NCI 5P30CA008748-51 7582 Bioinfomatics SOCCI, NICHOLAS SLOAN-KETTERING INST CAN RESEARCH NY $828,317
Prostate Cancer 2017 NCI 5R00CA160640-05 Tracing the origins of chromosomal translocations in prostate cancer MANI, RAM UT SOUTHWESTERN MEDICAL CENTER TX $249,000
Prostate Cancer 2017 NCI 5R01CA190554-03 Osteocytes in prostate cancer bone metastasis KELLER, EVAN UNIVERSITY OF MICHIGAN MI $354,563
Prostate Cancer 2017 NCI 5R01CA184208-03 Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer FRIGO, DANIEL UNIVERSITY OF HOUSTON TX $349,759
Prostate Cancer 2017 NIBIB 5R01EB020353-02 Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation BASILION, JAMES CASE WESTERN RESERVE UNIVERSITY OH $664,240
Prostate Cancer 2017 NCI 5R01CA200718-02 A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials EGGLY, SUSAN WAYNE STATE UNIVERSITY MI $599,514
Prostate Cancer 2017 NCI 5R00CA175290-05 An integrated approach to dissect the functional network of large non-coding RNA CHEN, YIWEN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $221,939
Prostate Cancer 2017 NCI 5R01CA202690-02 Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort MUCCI, LORELEI HARVARD SCHOOL OF PUBLIC HEALTH MA $393,034
Prostate Cancer 2017 NIGMS 1SC2GM121185-01 Development of Stabilized Zampanolide Mimics as Chemotherapeutics for Prostate Cancer CHEN, QIAOHONG CALIFORNIA STATE UNIVERSITY FRESNO CA $140,000
Prostate Cancer 2017 NCI 2P30CA006516-52 5398 Program 3: Prostate Cancer BALK, STEVEN BETH ISRAEL DEACONESS MEDICAL CENTER MA $40,304
Prostate Cancer 2017 NCI 5R01CA202814-02 Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging STEINMETZ, NICOLE CASE WESTERN RESERVE UNIVERSITY OH $394,519
Prostate Cancer 2017 NCI 2P30CA012197-42 6112 Tumor Progression and Recurrence (01) PASCHE, BORIS WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $49,492
Prostate Cancer 2017 NCI 5R01CA183857-04 Exploiting drivers of androgen receptor signaling negative prostate cancer for pr TOMLINS, SCOTT UNIVERSITY OF MICHIGAN MI $321,625
Prostate Cancer 2017 NCI 5R21CA202214-02 Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging HALPERN, ETHAN THOMAS JEFFERSON UNIVERSITY PA $206,883
Prostate Cancer 2017 NCI 5R01CA168601-05 Novel roles of microRNA in androgen receptor signaling GAO, ALLEN UNIVERSITY OF CALIFORNIA AT DAVIS CA $308,025
Prostate Cancer 2017 NCI 5R35CA197465-02 Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance RONAI, ZE'EV SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $1,137,453
Prostate Cancer 2017 NCI 5R35CA197684-02 IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells BALDWIN, ALBERT UNIV OF NORTH CAROLINA CHAPEL HILL NC $848,325
Prostate Cancer 2017 NIBIB 5R03EB022141-02 Towards an Effective Prostate Cancer-Targeting Biomaterial CONDA SHERIDAN, MARTIN UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $75,250
Prostate Cancer 2017 NCI 1R01CA212094-01 Inhibition of castration resistant prostate cancer by targeting of the IKKbeta/AR signaling DAN, HANCAI UNIVERSITY OF MARYLAND BALTIMORE MD $366,943
Prostate Cancer 2017 NCI 1R01CA211646-01 Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor ZETTER, BRUCE BOSTON CHILDREN'S HOSPITAL MA $415,154
Prostate Cancer 2017 NCI 5R01CA157429-05 Overcoming drug resistance of castration-resistant prostate cancer LIU, XIAOQI PURDUE UNIVERSITY IN $257,688
Prostate Cancer 2017 NCI 5R01CA182435-03 Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis DATTA, KAUSTUBH UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $344,269
Prostate Cancer 2017 NCI 5R01CA192894-02 Enhancing anti-neoplastic activity of metformin in prostate cancer LIU, XIAOQI PURDUE UNIVERSITY IN $357,624
Prostate Cancer 2017 NIGMS 5R01GM111084-03 Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery TSAI, FRANCIS BAYLOR COLLEGE OF MEDICINE TX $340,642
Prostate Cancer 2017 NCI 5R01CA183965-04 Role of TOP2B in generating complex genomic rearrangements in human cancer YEGNASUBRAMANIAN, SRINIVASAN JOHNS HOPKINS UNIVERSITY MD $336,150
Prostate Cancer 2017 NCI 5R01CA200551-02 A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR PARK, SEAN MAYO CLINIC ROCHESTER MN $247,249
Prostate Cancer 2017 NCI 5R01CA160902-06 Advancement and Validation of Prostate Diffusion and Spectroscopic MRI MAIER, STEPHAN BRIGHAM AND WOMEN'S HOSPITAL MA $220,860
Prostate Cancer 2017 NCI 1K99CA212292-01 Elucidating a Novel Mechanism for SPOP in Suppressing Prostate Tumorigenesis ZHANG, JINFANG BETH ISRAEL DEACONESS MEDICAL CENTER MA $168,804
Prostate Cancer 2017 NCI 1R21CA212516-01 Enhancing Survivorship Care Planning for Patients with Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program SONG, LIXIN UNIV OF NORTH CAROLINA CHAPEL HILL NC $198,360
Prostate Cancer 2017 NCI 1R21CA213020-01 Hyperpolarized 13C imaging of mitochondrial metabolism for improved characterization of prostate cancer MAYER, DIRK UNIVERSITY OF MARYLAND BALTIMORE MD $167,702
Prostate Cancer 2017 NCI 5R01CA176844-05 The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer VASIOUKHIN, VALERI FRED HUTCHINSON CANCER RESEARCH CENTER WA $362,148
Prostate Cancer 2017 NCI 5R01CA178431-04 Function of the Stem Cell Transcription Factor Sox2 in Prostate Cancer VANDER GRIEND, DONALD UNIVERSITY OF CHICAGO IL $323,229
Prostate Cancer 2017 NCI 1R21CA213157-01 Radiolabeled FASN Inhibitors for PET Imaging BABICH, JOHN WEILL MEDICAL COLL OF CORNELL UNIV NY $229,013
Prostate Cancer 2017 NCI 5R01CA169524-05 Role of RNF6 in survival signaling QIU, YUN UNIVERSITY OF MARYLAND BALTIMORE MD $318,513
Prostate Cancer 2017 NCI 5R01CA186780-22 Roles of EAF2 in androgen action in the prostate WANG, ZHOU UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $371,525
Prostate Cancer 2017 NCI 5R01CA112226-08 Transcription repression in prostate cancer LOGAN, SUSAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $402,563
Prostate Cancer 2017 NCI 5R01CA193910-03 Defining the epigenetic landscape in human prostate cancer FREEDMAN, MATTHEW DANA-FARBER CANCER INST MA $633,613
Prostate Cancer 2017 NCI 1R03CA212556-01 Loss of novel end joining factor with dysfunction of BRCA1 contributes to treatment resistance TOMIDA, JUNYA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $80,000
Prostate Cancer 2017 NCI 1R03CA212567-01 the role of EZH2 in neuroendocrine prostate cancer YU, XIUPING LOUISIANA STATE UNIV HSC SHREVEPORT LA $72,500
Prostate Cancer 2017 NCI 1R15CA202984-01A1 Oncolytic reovirus modulation of the cancer cell hypoxic response MILLER, CATHY IOWA STATE UNIVERSITY IA $441,245
Prostate Cancer 2017 NCI 5F30CA196108-03 Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer BADER, DAVID BAYLOR COLLEGE OF MEDICINE TX $38,455
Prostate Cancer 2017 NCI 5R01CA127923-10 IKK and the Control of Prostate Cancer Metastasis KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $257,099
Prostate Cancer 2017 NCI 5R01CA174798-05 Endothelial-to-osteoblast transition in prostate cancer bone metastasis LIN, SUE-HWA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $88,988
Prostate Cancer 2017 NCI 5R01CA172576-04 Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents CHEN, CHING-SHIH OHIO STATE UNIVERSITY OH $319,550
Prostate Cancer 2017 NCI 2R01CA105304-11A1 Delineating the mechanisms of androgen receptor activation function-1 antagonists for development of novel prostate cancer therapeutics SADAR, MARIANNE BRITISH COLUMBIA CANCER AGENCY CANADA $260,847
Prostate Cancer 2017 NCI 5R01CA197516-02 3D Prostate Histochemometry to Predict Disease Recurrence BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $400,626
Prostate Cancer 2017 NCI 5K23CA197526-02 Overcoming drug resistance in metastatic castration resistant prostate cancer with a novel combination of TGF-beta inhibition and enzalutamide PALLER, CHANNING JOHNS HOPKINS UNIVERSITY MD $177,120
Prostate Cancer 2017 NCI 1R01CA201035-01A1 Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate Cancer THOREK, DANIEL JOHNS HOPKINS UNIVERSITY MD $373,340
Prostate Cancer 2017 NCI 1R01CA203930-01A1 Biobehavioral Effects of Qigong for Prostate Cancer Survivors with Fatigue KINNEY, ANITA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $623,021
Prostate Cancer 2017 NCI 5R01CA204430-02 Mitochondria in Prostate Cancer Diversity SINGH, KESHAV UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $336,263
Prostate Cancer 2017 NCI 1R01CA204254-01A1 Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention FEI, BAOWEI EMORY UNIVERSITY GA $376,753
Prostate Cancer 2017 NCI 5R21CA194798-02 Exploring high-does testosterone as a potential treatment for abiraterone-resistant prostate cancer COREY, EVA UNIVERSITY OF WASHINGTON WA $201,623
Prostate Cancer 2017 NCI 5R21CA197887-02 Autophagy regulation of prostate tumor development THORBURN, ANDREW UNIVERSITY OF COLORADO DENVER CO $169,106
Prostate Cancer 2017 NCI 1R01CA206592-01A1 Structural Mechanisms of Hedgehog Autoprocessing in Physiology and Disease WANG, CHUNYU RENSSELAER POLYTECHNIC INSTITUTE NY $400,728
Prostate Cancer 2017 NIDDK 1R01DK109314-01A1 The microtubule cytoskeleton as a novel target for cavernous nerve regeneration after prostatectomy DAVIES, KELVIN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $578,367
Prostate Cancer 2017 NCI 5R01CA206222-02 Targeting key orphan nuclear receptor in lethal prostate cancer CHEN, HONGWU UNIVERSITY OF CALIFORNIA AT DAVIS CA $359,138
Prostate Cancer 2017 NIEHS 5R01ES014032-08 Cancer in adults following in utero and early life exposure to arsenic STEINMAUS, CRAIG UNIVERSITY OF CALIFORNIA BERKELEY CA $443,807
Prostate Cancer 2017 NCI 5K08CA175154-06 Defining the role of eIF4F in metastatic castration resistant prostate cancer HSIEH, ANDREW FRED HUTCHINSON CANCER RESEARCH CENTER WA $169,560
Prostate Cancer 2017 NCI 2U01CA167552-06 Cancer Epidemiology Cohort in Male Health Professionals WILLETT, WALTER HARVARD SCHOOL OF PUBLIC HEALTH MA $1,884,447
Prostate Cancer 2017 NCI 5R01CA125535-10 Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes JONES, KATHERINE SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $452,288
Prostate Cancer 2017 NCI 5R01CA193837-03 Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity SAWYERS, CHARLES SLOAN-KETTERING INST CAN RESEARCH NY $468,128
Prostate Cancer 2017 NCI 5R01CA181802-04 Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis CHAN, JUNE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $627,846
Prostate Cancer 2017 NCI 5R00CA184397-04 Proteolytically Cleaved Receptors as Oncogenes and Therapeutic Targets STOYANOVA, TANYA STANFORD UNIVERSITY CA $242,996
Prostate Cancer 2017 NCI 5F30CA203472-02 Clinical bacterial isolate engineered as an immunotherapy for prostate cancer ANKER, JONATHAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $49,044
Prostate Cancer 2017 NCI 5R01CA191002-02 The role of PLK1 in prostate cancer FU, ZHENG VIRGINIA COMMONWEALTH UNIVERSITY VA $348,844
Prostate Cancer 2017 NCI 5R21CA199171-02 Genetic Signatures Underlying Prostate Cancer Metastasis in AfricanAmericans FARUQUE, MEZBAH HOWARD UNIVERSITY DC $131,370
Prostate Cancer 2017 NCI 5R01CA123484-10 Role of Oncogenic Kinase Pim-1 in Prostate Cancer ABDULKADIR, SARKI NORTHWESTERN UNIVERSITY AT CHICAGO IL $284,744
Prostate Cancer 2017 NCI 5R01CA168899-05 Cooperative steroidogenic inhibition for treatment of advanced prostate cancer SHARIFI, NIMA CLEVELAND CLINIC LERNER COM-CWRU OH $326,897
Prostate Cancer 2017 NCI 5R01CA193481-03 Sequence-specific Capture for Discovering Protein-IncRNA Interactions in Prostate Cancer SMITH, LLOYD UNIVERSITY OF WISCONSIN-MADISON WI $344,168
Prostate Cancer 2017 NIGMS 5R01GM086596-07 Activation of androgen biosynthesis and drug metabolism by cytochrome b5 AUCHUS, RICHARD UNIVERSITY OF MICHIGAN MI $338,571
Prostate Cancer 2017 NCI 5R01CA174777-05 AR Gene Rearrangements and AR Signaling in Prostate Cancer DEHM, SCOTT UNIVERSITY OF MINNESOTA MN $310,149
Prostate Cancer 2017 NCI 5R01CA171189-05 Bidirectional role of KLF5 in prostatic epithelial homeostasis and tumorigenesis DONG, JIN-TANG EMORY UNIVERSITY GA $323,700
Prostate Cancer 2017 NCI 5R44CA203199-02 Novel Androgen Receptor Degraders to Treat Castration-Resistant Prostate Cancer TAYLOR, IAN ARVINAS, INC. CT $402,226
Prostate Cancer 2017 NCI 5K99CA194289-02 MDSC-tumor crosstalk in prostate cancer progression and castration resistance WANG, GUOCAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $104,445
Prostate Cancer 2017 NCI 5F30CA203517-02 Role of Neutrophil Elastase in Castration-Sensitive and Resistant Prostate Cancer LERMAN, IRINA UNIVERSITY OF ROCHESTER NY $49,044
Prostate Cancer 2017 NCI 5R01CA125612-09 Towards Understanding Prostate Cancer Heterogeneity RUBIN, MARK WEILL MEDICAL COLL OF CORNELL UNIV NY $372,410
Prostate Cancer 2017 NCI 5R01CA157372-06 VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer THAKUR, MATHEW THOMAS JEFFERSON UNIVERSITY PA $380,300
Prostate Cancer 2017 NCI 5R01CA176671-05 Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET LEWIS, JASON SLOAN-KETTERING INST CAN RESEARCH NY $563,930
Prostate Cancer 2017 NCI 5R21CA196570-02 Reprogramming of Prostate Stromal Cells by Prostate Inflammation XIN, LI BAYLOR COLLEGE OF MEDICINE TX $185,247
Prostate Cancer 2017 NCI 5R01CA115746-10 Characterizing Prostate Cancer By ex vivo MRS Signatures CHENG, LEO MASSACHUSETTS GENERAL HOSPITAL MA $556,388
Prostate Cancer 2017 NCI 5R01CA187918-03 Targeting the p110beta isoform of PI3 kinase in prostate cancer ROBERTS, THOMAS DANA-FARBER CANCER INST MA $554,053
Prostate Cancer 2017 NCI 5R00CA181342-04 Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy LIU, PENGDA UNIV OF NORTH CAROLINA CHAPEL HILL NC $217,518
Prostate Cancer 2017 NCI 5R01CA197944-02 Development of cancer therapeutic TBK1/IKKi dual inhibitors LUO, JUN-LI SCRIPPS FLORIDA FL $439,200
Prostate Cancer 2017 NCI 5R01CA205400-02 Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target ST CLAIR, DARET UNIVERSITY OF KENTUCKY KY $339,072
Prostate Cancer 2017 NCI 5R01CA188015-03 Discovery of Selective MAP2K4 Inhibitors to Target Metastasis SCHEIDT, KARL NORTHWESTERN UNIVERSITY IL $346,802
Prostate Cancer 2017 NCI 5R01CA188427-03 Regulation of tyrosine kinase signaling through interaction with membrane lipids TYNER, ANGELA UNIVERSITY OF ILLINOIS AT CHICAGO IL $430,308
Prostate Cancer 2017 NCI 5K99CA197804-02 Epigenetic Mechanisms Controlling T-cell Exhaustion in Prostate Cancer KISSICK, HAYDN EMORY UNIVERSITY GA $111,730
Prostate Cancer 2017 NCI 5R01CA172384-05 The Role of NOV (CCN3) in Prostate Cancer Progression YU, JINDAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $320,588
Prostate Cancer 2017 NIDDK 5R01DK092202-07 Prostate Epithelial Lineage Hierarchy XIN, LI BAYLOR COLLEGE OF MEDICINE TX $356,625
Prostate Cancer 2017 NIMHD 5R01MD008934-04 Decision Aids to Address Prostate Cancer Disparities in Minority Men TILBURT, JON MAYO CLINIC ROCHESTER MN $358,055
Prostate Cancer 2017 NCI 5R01CA198097-02 Co-targeting oncogenic pathways in advanced prostate cancer CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $381,212
Prostate Cancer 2017 NCI 5R01CA200859-02 Hardwiring Mechanism into Predicting Cancer Phenotypes by Computational Learning MARCHIONNI, LUIGI JOHNS HOPKINS UNIVERSITY MD $384,981
Prostate Cancer 2017 NCI 5R01CA189765-03 CXCL13: a mediator of prostate cancer progression KAZANIETZ, MARCELO UNIVERSITY OF PENNSYLVANIA PA $356,098
Prostate Cancer 2017 NCI 1F32CA213742-01 Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities GRAHAM, MINDY JOHNS HOPKINS UNIVERSITY MD $57,066
Prostate Cancer 2017 NCI 5R01CA154387-05 Inhibiting serine protease-induced prostate cancer progression RADISKY, EVETTE MAYO CLINIC JACKSONVILLE FL $325,287
Prostate Cancer 2017 NIGMS 5SC1CA180212-05 Role of CCL25-CCR9 in Prostate Cancer SINGH, SHAILESH MOREHOUSE SCHOOL OF MEDICINE GA $353,750
Prostate Cancer 2017 NCI 1F31CA203036-01A1 Bone Marrow Adipocytes Alter the Metabolic Phenotype of Metastatic Prostate Cancer Cells Through the Activation of HIF-1a DIEDRICH, JONATHAN WAYNE STATE UNIVERSITY MI $28,447
Prostate Cancer 2017 NCI 5U01CA113913-12 Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center SANDA, MARTIN EMORY UNIVERSITY GA $874,523
Prostate Cancer 2017 NCI 5R01CA123362-06 PDGF D and Prostate Cancer Bone Metastasis KIM, HYEONG-REH WAYNE STATE UNIVERSITY MI $354,346
Prostate Cancer 2017 NCI 5R01CA175779-05 Phosphatidylserine Targeted Tumor Cell Lytic Peptoids UDUGAMASOORIYA, DAMITH UNIVERSITY OF HOUSTON TX $281,989
Prostate Cancer 2017 NCI 5U01CA185490-04 Molecular determinant of racial disparity in prostate cancer SINGH, AJAY UNIVERSITY OF SOUTH ALABAMA AL $314,363
Prostate Cancer 2017 NINR 1R01NR016483-01A1 Decision Navigation for Advanced Prostate Cancer Treatment Options using mHealth JONES, RANDY UNIVERSITY OF VIRGINIA VA $491,732
Prostate Cancer 2017 NCI 5R01CA185297-03 The aberrant androgen receptor underlies abiraterone/enzalutamide resistance LUO, JUN JOHNS HOPKINS UNIVERSITY MD $370,575
Prostate Cancer 2017 NCI 5P30CA016087-37 6482 GENITOURINARY CANCERS CARROLL, WILLIAM NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $27,088
Prostate Cancer 2017 NCI 5U24CA115102-12 Clinical and Analytical Validation of Cancer Biomarkers CHAN, DANIEL JOHNS HOPKINS UNIVERSITY MD $486,000
Prostate Cancer 2017 NCI 5R21CA205108-02 A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer MOHLER, JAMES ROSWELL PARK CANCER INSTITUTE CORP NY $259,734
Prostate Cancer 2017 NCI 9R13MD011368-04 African Caribbean Cancer Consortium Scientific and Training Conference RAGIN, CAMILLE RESEARCH INST OF FOX CHASE CAN CTR PA $24,000
Prostate Cancer 2017 NIMHD 9R13MD011368-04 African Caribbean Cancer Consortium Scientific and Training Conference RAGIN, CAMILLE RESEARCH INST OF FOX CHASE CAN CTR PA $50,000
Prostate Cancer 2017 NCI 5U01CA152813-07 Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer ZHANG, HUI JOHNS HOPKINS UNIVERSITY MD $549,721
Prostate Cancer 2017 NCI 5R01CA184228-04 Small Molecule PSMA-Targeted Alpha Therapy POMPER, MARTIN JOHNS HOPKINS UNIVERSITY MD $418,621
Prostate Cancer 2017 NCI 5R01CA178338-04 Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer GIOELI, DANIEL UNIVERSITY OF VIRGINIA VA $327,850
Prostate Cancer 2017 NCI 5R01CA183882-03 HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions JOHNSTON, PAUL UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $338,926
Prostate Cancer 2017 NCI 5R01CA172169-05 PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM LU, JUNXUAN PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $90,971
Prostate Cancer 2017 NCI 5R01CA179100-04 Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis RICKMAN, DAVID WEILL MEDICAL COLL OF CORNELL UNIV NY $428,881
Prostate Cancer 2017 NCI 5R01CA204786-02 Modulation of host intrinsic immunity to reduce prostate cancer disparity KARAN, DEV UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $1
Prostate Cancer 2017 NCI 5R01CA193678-02 Hemostatic Factors Drive Prostate Cancer Pathogenesis PALUMBO, JOSEPH CINCINNATI CHILDRENS HOSP MED CTR OH $356,850
Prostate Cancer 2017 NCI 5R01CA184012-04 Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer DENMEADE, SAMUEL JOHNS HOPKINS UNIVERSITY MD $261,450
Prostate Cancer 2017 NCI 5R01CA196947-02 Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery FIGUEIREDO, MARXA PURDUE UNIVERSITY IN $350,644
Prostate Cancer 2017 NCI 5F32CA196080-02 Investigating the role of autophagy in Tak1 null prostate cancer and TRAIL sensitivity GOODALL, MEGAN UNIVERSITY OF COLORADO DENVER CO $59,166
Prostate Cancer 2017 NCI 5R01CA179129-05 Bone metabolism and bone metastases in prostate cancer WILSON, KATHRYN HARVARD SCHOOL OF PUBLIC HEALTH MA $207,639
Prostate Cancer 2017 NCI 5R01CA132641-19 The Biology of Prostate Stem Cells - Resubmission - 1 WILSON, ELAINE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $394,769
Prostate Cancer 2017 NCI 5U54CA193313-03 7218 Project 1: Modeling tumor evolution in mouse and organoid models RABADAN, RAUL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $398,421
Prostate Cancer 2017 NCI 5R21CA205257-02 The Role of Mitochondrial Heterogeneity in Pyruvate Flux in Prostate Cancer Progression MCGUIRE, SEAN BAYLOR COLLEGE OF MEDICINE TX $172,369
Prostate Cancer 2017 NCI 1R41CA214080-01 Anti-CCL25 mAb to treat castration resistant prostate cancer SINGH, SHAILESH JYANT, INC. GA $350,000
Prostate Cancer 2017 NCI 5R01CA199741-03 CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer CRAMER, SCOTT UNIVERSITY OF COLORADO DENVER CO $341,879
Prostate Cancer 2017 NCI 5R01CA177984-04 MicroRNAs in frequently deleted loci regulate prostate cancer EMT and metastasis SAINI, SHARANJOT NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $383,250
Prostate Cancer 2017 NCI 5R01CA192402-03 Estimating Overdiagnosis in Cancer Screening Studies ETZIONI, RUTH FRED HUTCHINSON CANCER RESEARCH CENTER WA $614,029
Prostate Cancer 2017 NCI 5R01CA197996-02 Leveraging the methionine salvage pathway as a novel therapy for prostate cancer. SMIRAGLIA, DOMINIC ROSWELL PARK CANCER INSTITUTE CORP NY $389,441
Prostate Cancer 2017 NCI 5R01CA169300-05 Targeting Cathepsin L: A Novel Strategy to Impede Prostate and Breast Cancer Meta SIEMANN, DIETMAR UNIVERSITY OF FLORIDA FL $311,250
Prostate Cancer 2017 NCI 5P01CA098912-13 8454 Core A: Biostatistics and Bioinformatics Core TIGHIOUART, MOURAD CEDARS-SINAI MEDICAL CENTER CA $121,627
Prostate Cancer 2017 NCI 5P01CA098912-13 8455 Core B: Pathology and High-resolution Imaging Core ZAYZAFOON, MAJD CEDARS-SINAI MEDICAL CENTER CA $168,654
Prostate Cancer 2017 NCI 5P01CA098912-13 8456 Project 1: Molecular Mechanisms Initiating Prostate Cancer Metastasis CHUNG, LELAND CEDARS-SINAI MEDICAL CENTER CA $282,822
Prostate Cancer 2017 NCI 5P01CA098912-13 8457 Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis FARACH-CARSON, MARY RICE UNIVERSITY TX $281,091
Prostate Cancer 2017 NCI 5P01CA098912-13 8458 Project 3: Prostatic Epithelial Stromal Interactions Facilitate Bone Metastasis BHOWMICK, NEIL CEDARS-SINAI MEDICAL CENTER CA $283,400
Prostate Cancer 2017 NCI 5P01CA098912-13 8459 Project 4: Cholesterol Metabolism and Prostate Cancer Metastasis FREEMAN, MICHAEL CEDARS-SINAI MEDICAL CENTER CA $258,344
Prostate Cancer 2017 NCI 5P01CA098912-13 8460 Program Integration and Management CHUNG, LELAND CEDARS-SINAI MEDICAL CENTER CA $55,758
Prostate Cancer 2017 NCI 5R01CA168393-04 SOX9 Mediation of AR and ERG Driven Prostate Cancer BALK, STEVEN BETH ISRAEL DEACONESS MEDICAL CENTER MA $361,050
Prostate Cancer 2017 NCI 5R01CA206189-02 Nanoparticle-mediated treatment for bone metastasis LABHASETWAR, VINOD CLEVELAND CLINIC LERNER COM-CWRU OH $312,562
Prostate Cancer 2017 NCI 5R01CA173481-05 Preclinical analyses of advanced prostate cancer in genetically-engineered mice ABATE-SHEN, CORY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $389,781
Prostate Cancer 2017 NCI 5U01CA185148-03 MIC-1 and its functional partners in prostate cancer racial disparity BATRA, SURINDER UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $312,080
Prostate Cancer 2017 NCI 5F30CA192896-03 IL-1b-mediated tumor-stromal interaction and prostate cancer cell cooperation in the bone metastatic niche SHAHRIARI, KRISTINA DREXEL UNIVERSITY PA $49,044
Prostate Cancer 2017 NCI 5R00CA166507-05 Molecular basis of androgen receptor mediated gene transcriptional repression CAI, CHANGMENG UNIVERSITY OF MASSACHUSETTS BOSTON MA $237,796
Prostate Cancer 2017 NCI 5P30CA016056-40 8364 Genitourinary Cancers Program TRUMP, DONALD ROSWELL PARK CANCER INSTITUTE CORP NY $70,515
Prostate Cancer 2017 NCI 5P30CA016056-40 8380 Mouse Tumor Model Shared Resource TRUMP, DONALD ROSWELL PARK CANCER INSTITUTE CORP NY $102,861
Prostate Cancer 2017 NCI 5R01CA172801-05 Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards KARCZMAR, GREGORY UNIVERSITY OF CHICAGO IL $465,411
Prostate Cancer 2017 NCI 5R01CA174714-05 The role of IL-17 in prostate cancer YOU, ZONGBING TULANE UNIVERSITY OF LOUISIANA LA $312,288
Prostate Cancer 2017 NIGMS 5P20GM109091-04 8002 Targeting COPZl in miR-152 deficient tumor cells SHTUTMAN, MICHAEL UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $217,202
Prostate Cancer 2017 NINR 5K01NR015246-03 Mitochondrial Bioenergetic Mechanism of Cancer Related Fatigue HSIAO, CHAO-PIN CASE WESTERN RESERVE UNIVERSITY OH $90,990
Prostate Cancer 2017 NIBIB 5R01EB019288-04 Polymeric nanoparticles with imaging capability for therapeutic peptide delivery PEREZ, J CEDARS-SINAI MEDICAL CENTER CA $292,627
Prostate Cancer 2017 NCI 5R01CA179059-04 Enhancement of BB2r-Targeted Radiotherapy for Prostate Cancer Utilizing Hypoxia-S GARRISON, JERED UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $312,288
Prostate Cancer 2017 NINR 5R01NR014502-03 A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer BHASIN, SHALENDAR BRIGHAM AND WOMEN'S HOSPITAL MA $687,002
Prostate Cancer 2017 NCI 5R00CA178199-05 Polycomb -Independent Functions of EZH2 in Castration Resistant Prostate Cancer XU, KEXIN UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $1
Prostate Cancer 2017 NCI 5R01CA025836-37 Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers KATZENELLENBOGEN, JOHN UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $420,805
Prostate Cancer 2017 NCI 2P30CA006973-54 8089 Prostate Cancer Program - 07 PIENTA, KENNETH JOHNS HOPKINS UNIVERSITY MD $55,301
Prostate Cancer 2017 NCI 5R21CA202199-02 Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer RAY, SANGEETA JOHNS HOPKINS UNIVERSITY MD $189,338
Prostate Cancer 2017 NCI 5R01CA181654-03 Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy NARLA, GOUTHAM CASE WESTERN RESERVE UNIVERSITY OH $374,305
Prostate Cancer 2017 NCI 5R01CA185509-04 (PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc GHOSH, PARAMITA UNIVERSITY OF CALIFORNIA AT DAVIS CA $258,128
Prostate Cancer 2017 NCI 5R01CA184075-03 PALS: Prostate Cancer Active Lifestyle Study WRIGHT, JONATHAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $610,584
Prostate Cancer 2017 NCI 5P30CA056036-18 7223 Biology of Prostate Cancer KNUDSEN, KAREN THOMAS JEFFERSON UNIVERSITY PA $27,080
Prostate Cancer 2017 NCI 5R01CA200573-02 Characterizing the signaling pathways that regulate Skp2 oncogenic function WEI, WENYI BETH ISRAEL DEACONESS MEDICAL CENTER MA $395,738
Prostate Cancer 2017 NCI 5R01CA166440-04 Towards selective androgen deprivation by targeting androgen activation of SRF HEEMERS, HANNELORE CLEVELAND CLINIC LERNER COM-CWRU OH $149,738
Prostate Cancer 2017 NCI 5P30CA013696-43 6104 Prostate Cancer Program EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $35,133
Prostate Cancer 2017 NCI 5R01CA199663-03 Image-guided radiation-induced permeability (IGRIP) for IGDD KRON, STEPHEN UNIVERSITY OF CHICAGO IL $492,442
Prostate Cancer 2017 NCI 5R01CA190378-03 The Notch Signaling in Prostate Homeostasis and Carcinogenesis XIN, LI BAYLOR COLLEGE OF MEDICINE TX $362,569
Prostate Cancer 2017 NIGMS 5R01GM107427-04 Utilizing genetic and functional strategies to identify causal genes and alleles FREEDMAN, MATTHEW DANA-FARBER CANCER INST MA $484,483
Prostate Cancer 2017 NCI 1R01CA214872-01 Parp Function in Prostate Cancer PASCHAL, BRYCE UNIVERSITY OF VIRGINIA VA $370,478
Prostate Cancer 2017 NCI 5R01CA201458-02 Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis ZHU, LIANG ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $382,013
Prostate Cancer 2017 NCI 5R01CA134514-09 Role of FOXO1 Inactivation in Prostate Tumorigenesis HUANG, HAOJIE MAYO CLINIC ROCHESTER MN $357,750
Prostate Cancer 2017 NCI 5R01CA187273-03 Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin RANGNEKAR, VIVEK UNIVERSITY OF KENTUCKY KY $344,269
Prostate Cancer 2017 NCI 1R01CA215550-01 Brain-Selective Therapy to Alleviate Hot Flushes of Prostate Cancer Patients PROKAI, LASZLO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $355,055
Prostate Cancer 2017 NCI 1R01CA217817-01 Molecular Probes Shed Light on Magnesium Homeostasis BUCCELLA, DANIELA NEW YORK UNIVERSITY NY $348,180
Prostate Cancer 2017 NCI 1R01CA214554-01 CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING KURHANEWICZ, JOHN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $684,591
Prostate Cancer 2017 NCI 5R01CA197160-03 Neuroendocrine mechanisms of prostate cancer progression NIKITIN, ALEXANDER CORNELL UNIVERSITY NY $348,145
Prostate Cancer 2017 NCI 5U01CA202958-02 Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer BASANTA GUTIERREZ, DAVID H. LEE MOFFITT CANCER CTR & RES INST FL $690,824
Prostate Cancer 2017 NCI 5R01CA193967-02 The NEDD8 pathway mediated Skp2 degradation in chemoprevention by FKA ZI, XIAOLIN UNIVERSITY OF CALIFORNIA-IRVINE CA $353,419
Prostate Cancer 2017 NCI 5R01CA182569-03 USP22 Function in Advanced Prostate Cancer KNUDSEN, KAREN THOMAS JEFFERSON UNIVERSITY PA $493,498
Prostate Cancer 2017 NCI 5F31CA200390-02 The Ron Receptor in Castration Resistant Prostate Cancer BROWN, NICHOLAS UNIVERSITY OF CINCINNATI OH $33,653
Prostate Cancer 2017 NCI 5K08CA187417-04 Genomic instability and DNA repair in a distinct molecular class of prostate canc BARBIERI, CHRISTOPHER WEILL MEDICAL COLL OF CORNELL UNIV NY $172,908
Prostate Cancer 2017 NCI 5R21CA183679-03 Microfluidic Western Blotting for Targeted Proteomic Analysis of Single Circulating Tumor Cells HERR, AMY UNIVERSITY OF CALIFORNIA BERKELEY CA $181,878
Prostate Cancer 2017 NCI 5R01CA178846-05 MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES SLINGLUFF, CRAIG UNIVERSITY OF VIRGINIA VA $394,792
Prostate Cancer 2017 NCI 5P30CA043703-27 5473 TISSUE RESOURCES CORE FACILITY GERSON, STANTON CASE WESTERN RESERVE UNIVERSITY OH $151,408
Prostate Cancer 2017 NIBIB 5U01EB012493-08 Point-of care Microfluidics for Early Detection of Cancer TONER, MEHMET MASSACHUSETTS GENERAL HOSPITAL MA $2,082,080
Prostate Cancer 2017 NCI 5R01CA172495-05 Targeting myristoylation of Src family kinases for inhibition of prostate tumorig CAI, HOUJIAN UNIVERSITY OF GEORGIA GA $311,250
Prostate Cancer 2017 NCI 5R01CA197477-02 Hypoxia: Impact on Src Signaling and Prostate Cancer SIEMANN, DIETMAR UNIVERSITY OF FLORIDA FL $344,053
Prostate Cancer 2017 NIGMS 5SC2CA200520-03 Novel Hyperpolarized Agents for Metabolic Imaging of Cancer BILLINGSLEY, KELVIN SAN FRANCISCO STATE UNIVERSITY CA $1
Prostate Cancer 2017 NCI 5R01CA185251-04 [PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis BEEBE, DAVID UNIVERSITY OF WISCONSIN-MADISON WI $700,207
Prostate Cancer 2017 NCI 5R01CA174294-05 Multifunctional immunoPET tracers for pancreatic and prostate cancer WU, ANNA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $444,176
Prostate Cancer 2017 NCI 1R01CA204806-01A1 Consequences and mechanism of aberrant splicing in African American prostate cancer disparities LEE, NORMAN GEORGE WASHINGTON UNIVERSITY DC $376,409
Prostate Cancer 2017 NCI 5P01CA134294-10 7461 Methods for Comparative Effectiveness Research in Cancer HERNAN, MIGUEL HARVARD SCHOOL OF PUBLIC HEALTH MA $220,122
Prostate Cancer 2017 NCI 5R01CA206456-02 Culturally Adapted Cognitive Behavioral Stress and Self-Management (C-CBSM) Intervention for PC PENEDO, FRANK NORTHWESTERN UNIVERSITY AT CHICAGO IL $638,319
Prostate Cancer 2017 NCI 1R03CA208221-01A1 Increased chemoprevention by a mixture of three phytochemicals in prostate cancer WANG, PIWEN CHARLES R. DREW UNIVERSITY OF MED & SCI CA $78,526
Prostate Cancer 2017 NCI 5R21CA198820-02 Functions of histone variants in castration-resistance prostate cancer ISHOV, ALEXANDER UNIVERSITY OF FLORIDA FL $163,125
Prostate Cancer 2017 NCI 1R21CA205094-01A1 Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials NGWA, WILFRED DANA-FARBER CANCER INST MA $229,187
Prostate Cancer 2017 NCI 1R21CA216052-01 Prostate Cancer and Obesogenic Factors MACIAS, EVERARDO CEDARS-SINAI MEDICAL CENTER CA $203,914
Prostate Cancer 2017 NCI 5R01CA137050-08 Mechanism and treatment of PTEN mutant prostate tumorigenesis TROTMAN, LLOYD COLD SPRING HARBOR LABORATORY NY $398,400
Prostate Cancer 2017 NCI 5R01CA200423-15 Chemical Glycoproteomics BERTOZZI, CAROLYN STANFORD UNIVERSITY CA $349,310
Prostate Cancer 2017 NCI 5R21CA192185-03 Autophagy-mediated immune responses to oncolytic VSV HISCOTT, JOHN ISTITUTO PASTEUR ITALIA FONDAZIONE CENCI BOLOGNETTI ITALY $117,072
Prostate Cancer 2017 NCI 7R21CA202404-02 MicroRNAs Modulate Therapy Resistance in Prostate Cancer NADIMINTY, NAGALAKSHMI UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $200,318
Prostate Cancer 2017 NIBIB 5R01EB017449-05 Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods VIGNERON, DANIEL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $1,185,440
Prostate Cancer 2017 NIEHS 5R01ES011126-14 A NESTED CASE-CONTROL STUDY OF PROSTATE CARCINOGENESIS RYBICKI, BENJAMIN HENRY FORD HEALTH SYSTEM MI $473,334
Prostate Cancer 2017 NCI 5R01CA178610-04 The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer ALUMKAL, JOSHI OREGON HEALTH & SCIENCE UNIVERSITY OR $316,934
Prostate Cancer 2017 NCI 5R01CA200660-02 Targeting the MLL complex in Castration Resistant Prostate Cancer GREMBECKA, JOLANTA UNIVERSITY OF MICHIGAN MI $386,776
Prostate Cancer 2017 NCI 5R01CA205001-02 Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer. HUANG, JIAOTI DUKE UNIVERSITY NC $271,066
Prostate Cancer 2017 NCI 1R21CA206013-01A1 (PQ1) Cellular senescence as an initiating event in malignant transformation DAVID, GREGORY NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $203,400
Prostate Cancer 2017 NCI 5R01CA196270-03 Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer CHAKRAVARTI, DEBABRATA NORTHWESTERN UNIVERSITY AT CHICAGO IL $441,943
Prostate Cancer 2017 NCI 5U01CA086402-17 San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR) LEACH, ROBIN UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $337,606
Prostate Cancer 2017 NCI 5R21CA201865-02 Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness LIANG, GANGNING UNIVERSITY OF SOUTHERN CALIFORNIA CA $179,438
Prostate Cancer 2017 NCI 5R21CA196434-02 Supramolecular matrix materials for prostate cancer cell biology VANDER GRIEND, DONALD UNIVERSITY OF CHICAGO IL $197,500
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer